| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 01/22/2002 | CA2214872C Benzothiophene compounds, compositions and methods |
| 01/17/2002 | WO2002004440A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 01/17/2002 | WO2002004439A2 Thiophene retinoids |
| 01/17/2002 | WO2002004425A2 Viral polymerase inhibitors |
| 01/17/2002 | WO2002004416A2 Lactam metalloprotease inhibitors |
| 01/17/2002 | WO2001062726A3 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 01/17/2002 | WO2001055107A3 Aromatic amines and amides acting on the melanocortin receptors |
| 01/17/2002 | WO2001039759A3 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 01/17/2002 | WO2001019817A3 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| 01/17/2002 | US20020007070 For inhibiting loss of blood platelets; inhibiting formation of blood platelet aggregates, fibrin, thrombus, and embolus; anticoagulants embedded in devices for blood collection, circulation, storage (catheters, dialysis machines); stents |
| 01/17/2002 | US20020007065 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 01/17/2002 | US20020007062 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders |
| 01/17/2002 | US20020006958 Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof |
| 01/17/2002 | US20020006952 Kinase inhibitors; anticancer agents |
| 01/17/2002 | US20020006948 Central nervous system disorders; antiinflammatory agents |
| 01/17/2002 | US20020006936 Anticancer agents; restenosis |
| 01/17/2002 | US20020006929 Antiarrhythmia agent, antiproliferative agent |
| 01/17/2002 | US20020006922 Metalloprotease inhibitors |
| 01/17/2002 | US20020006920 Arylsulfonylamino hydroxamic acid derivatives |
| 01/17/2002 | CA2415505A1 Lactam metalloprotease inhibitors |
| 01/17/2002 | CA2413044A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 01/16/2002 | EP1171435A2 Pyrimidine-2-one derivatives as integrin receptor ligands |
| 01/16/2002 | EP1171423A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 01/16/2002 | EP1171422A1 Mmp inhibitor |
| 01/16/2002 | EP1171122A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/16/2002 | EP0880517B1 Quinazoline compounds |
| 01/16/2002 | EP0790246B1 Potentiator for nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof |
| 01/16/2002 | EP0638075B1 Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 01/16/2002 | CN1331689A 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles |
| 01/16/2002 | CN1331680A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/16/2002 | CN1331679A 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands |
| 01/16/2002 | CN1331677A Pyrrolidine derivatives-CCR-3 receptor antagonists |
| 01/16/2002 | CN1077890C 4-aminoethyoxy-indolone derivatives as dopamine D2 agonists |
| 01/15/2002 | US6339164 C2 substituted phenyl taxane derivatives and pharmaceutical compositions containing them |
| 01/15/2002 | US6339097 N-phenylamide and N-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them |
| 01/15/2002 | US6339089 Antihypoxic agents; chronic obstructive pulmonary disease; vasoconstriction; reduces blood partial pressure of carbon dioxide; respiratory disorders; under oxygen inhalation treatment |
| 01/15/2002 | US6339087 For therapy of inflammatory or allergic diseases are selected from asthma, allergic rhinitis, hypersensitivity lung diseases, hypersensitivity pneumonitis, eosinophilic pneumonias, inflammatory bowel diseases, psoriasis, dermatitis |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002551A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/10/2002 | WO2002002550A1 Novel pyrazinone derivatives |
| 01/10/2002 | WO2002002525A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 01/10/2002 | WO2002002524A1 Pyrrole derivatives for treating aids |
| 01/10/2002 | WO2002002521A2 Aroyl aminoacyl pyrrole compounds and their pharmaceutical use |
| 01/10/2002 | WO2001000615A8 Respiratory syncytial virus replication inhibitors |
| 01/10/2002 | US20020004513 Azacyclic compounds |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | US20020004501 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004494 Muscular disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004198 Detecting viricides; mix polypeptide samples, incubate with modulator of protein activity, monitor sample viricidal activity |
| 01/10/2002 | CA2414468A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/10/2002 | CA2413245A1 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 01/10/2002 | CA2413002A1 Novel pyrazinone derivatives |
| 01/10/2002 | CA2412270A1 Pyrrole derivatives for treating aids |
| 01/09/2002 | EP1170296A2 Process for the preparation of 3-aryl-benzofuran-2-ones |
| 01/09/2002 | EP1170289A2 Retroviral protease inhibiting compounds |
| 01/09/2002 | EP1169320A1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 01/09/2002 | EP1169316A1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| 01/09/2002 | EP1169038A1 Cyclic protein tyrosine kinase inhibitors |
| 01/09/2002 | EP0937072B1 THIENYLCYCLOHEXANONE DERIVATIVES AS LIGANDS OF THE GABA A alpha5 RECEPTOR SUBTYPE |
| 01/09/2002 | EP0918768B1 Aromatic amidine derivatives useful as selective thrombin inhibitors |
| 01/09/2002 | CN1330648A 4-aryloxindoles as inhibitor of JNK protein kinases |
| 01/09/2002 | CN1330647A 4-alkenyl (and alkynyl) oxindoles as inhibitors of cell cycle protein dependent kinases, in particular CDK2 |
| 01/09/2002 | CN1330638A Substituted benzo (de) isoquinoline-1,3-diones |
| 01/09/2002 | CN1330634A Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
| 01/08/2002 | US6337342 Bis-aryl or heteroaryl indoles |
| 01/08/2002 | CA2216100C Process for 2-substituted benzo¬b|thiophene compounds and intermediates thereof |
| 01/08/2002 | CA2205202C Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 01/08/2002 | CA2159450C 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors |
| 01/08/2002 | CA2019622C Substituted arylamines and heteroarylamines, their preparation process and pharmaceutical composition containing them |
| 01/03/2002 | WO2002000650A2 Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 01/03/2002 | WO2002000649A1 Substituted quinazoline derivatives and their use as inhibitors |
| 01/03/2002 | WO2002000644A1 Guanidine derivatives of quinazoline and quinoline for use in the treatment of autoimmune diseases |
| 01/03/2002 | WO2002000632A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 01/03/2002 | WO2002000620A1 Fatty acid synthase inhibitors |
| 01/03/2002 | WO2002000606A1 Biphenyl compound |
| 01/03/2002 | WO2001062233A3 Adenosine receptor modulators |
| 01/03/2002 | WO2001054501A3 Herbicidal composition |
| 01/03/2002 | WO2001051473A8 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 01/03/2002 | WO2001045689A3 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 01/03/2002 | WO2001040184A3 Methods for the syntheses of alfentanil, sufentanil and remifentanil |
| 01/03/2002 | WO2000050470A3 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 01/03/2002 | US20020002292 C7 taxane derivatives and pharmaceutical compositions containing them |
| 01/03/2002 | US20020002199 Suitable for treating type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance or obesity |
| 01/03/2002 | US20020002183 Benzamides and related inhibitors of factor Xa |
| 01/03/2002 | US20020002162 Synergistic methods and compositions for treating cancer |
| 01/03/2002 | US20020002158 Potentiation of glutamate receptor function; treating central nervous system disorders |
| 01/03/2002 | DE10027514A1 Liganden von Integrinrezeptoren Ligands of integrin |
| 01/03/2002 | CA2414512A1 Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 01/03/2002 | CA2412592A1 Substituted quinazoline derivatives and their use as inhibitors |
| 01/03/2002 | CA2411157A1 Benzodiazepines as inhibitors of hpv e1 helicase |
| 01/02/2002 | EP1165557A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |
| 01/02/2002 | EP1165554A1 New endothelin converting enzyme inhibitors, their production and their use |
| 01/02/2002 | EP1165553A1 C10 ester substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165552A1 C7 carbonate substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165551A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165550A1 C10 carbonate substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165549A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165545A1 Novel compounds |
| 01/02/2002 | EP1165516A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 01/02/2002 | EP1165514A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |